As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Subscribe to Curetis Newsletter
Curetis Publishes Business and Financial Update for the First Quarter 2018
Curetis to Hold Annual General Shareholders’ Meeting on June 21, 2018
ATS - American Thoracic Society 2018 - San Diego, USA - May 20 to 22, 2018
ASM - Microbe 2018 - Alanta, USA - June 8 to 10, 2018